| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |